Cargando…

Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients

The possible role of the naturally occurring deuterium in the regulation of cell division was first described in the 1990s. To investigate the mechanism of influence of deuterium (D) on cell growth, expression of 236 cancer-related and 536 kinase genes were tested in deuterium-depleted (40 and 80 pp...

Descripción completa

Detalles Bibliográficos
Autores principales: Kovács, Beáta Zs., Puskás, László G., Nagy, Lajos I., Papp, András, Gyöngyi, Zoltán, Fórizs, István, Czuppon, György, Somlyai, Ildikó, Somlyai, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777325/
https://www.ncbi.nlm.nih.gov/pubmed/35043700
http://dx.doi.org/10.1177/10732748211068963
_version_ 1784637044250640384
author Kovács, Beáta Zs.
Puskás, László G.
Nagy, Lajos I.
Papp, András
Gyöngyi, Zoltán
Fórizs, István
Czuppon, György
Somlyai, Ildikó
Somlyai, Gábor
author_facet Kovács, Beáta Zs.
Puskás, László G.
Nagy, Lajos I.
Papp, András
Gyöngyi, Zoltán
Fórizs, István
Czuppon, György
Somlyai, Ildikó
Somlyai, Gábor
author_sort Kovács, Beáta Zs.
collection PubMed
description The possible role of the naturally occurring deuterium in the regulation of cell division was first described in the 1990s. To investigate the mechanism of influence of deuterium (D) on cell growth, expression of 236 cancer-related and 536 kinase genes were tested in deuterium-depleted (40 and 80 ppm) and deuterium-enriched (300 ppm) media compared to natural D level (150 ppm). Among genes with expression changes exceeding 30% and copy numbers over 30 (124 and 135 genes, respectively) 97.3% of them was upregulated at 300 ppm D-concentration. In mice exposed to chemical carcinogen, one-year survival data showed that deuterium-depleted water (DDW) with 30 ppm D as drinking water prevented tumor development. One quarter of the treated male mice survived 344 days, the females 334 days, while one quarter of the control mice survived only 188 and 156 days, respectively. In our human retrospective study 204 previously treated cancer patients with disease in remission, who consumed DDW, were followed. Cumulative follow-up time was 1024 years, and average follow-up time per patient, 5 years (median: 3.6 years). One hundred and fifty-six patients out of 204 (77.9%) did not relapse during their 803 years cumulative follow-up time. Median survival time (MST) was not calculable due to the extremely low death rate (11 cancer-related deaths, 5.4% of the study population). Importantly, 8 out of 11 deaths occurred several years after stopping DDW consumption, confirming that regular consumption of DDW can prevent recurrence of cancer. These findings point to the likely mechanism in which consumption of DDW keeps D-concentration below natural levels, preventing the D/H ratio from increasing to the threshold required for cell division. This in turn can serve as a key to reduce the relapse rate of cancer patients and/or to reduce cancer incidence in healthy populations.
format Online
Article
Text
id pubmed-8777325
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-87773252022-01-22 Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients Kovács, Beáta Zs. Puskás, László G. Nagy, Lajos I. Papp, András Gyöngyi, Zoltán Fórizs, István Czuppon, György Somlyai, Ildikó Somlyai, Gábor Cancer Control Original Research Article The possible role of the naturally occurring deuterium in the regulation of cell division was first described in the 1990s. To investigate the mechanism of influence of deuterium (D) on cell growth, expression of 236 cancer-related and 536 kinase genes were tested in deuterium-depleted (40 and 80 ppm) and deuterium-enriched (300 ppm) media compared to natural D level (150 ppm). Among genes with expression changes exceeding 30% and copy numbers over 30 (124 and 135 genes, respectively) 97.3% of them was upregulated at 300 ppm D-concentration. In mice exposed to chemical carcinogen, one-year survival data showed that deuterium-depleted water (DDW) with 30 ppm D as drinking water prevented tumor development. One quarter of the treated male mice survived 344 days, the females 334 days, while one quarter of the control mice survived only 188 and 156 days, respectively. In our human retrospective study 204 previously treated cancer patients with disease in remission, who consumed DDW, were followed. Cumulative follow-up time was 1024 years, and average follow-up time per patient, 5 years (median: 3.6 years). One hundred and fifty-six patients out of 204 (77.9%) did not relapse during their 803 years cumulative follow-up time. Median survival time (MST) was not calculable due to the extremely low death rate (11 cancer-related deaths, 5.4% of the study population). Importantly, 8 out of 11 deaths occurred several years after stopping DDW consumption, confirming that regular consumption of DDW can prevent recurrence of cancer. These findings point to the likely mechanism in which consumption of DDW keeps D-concentration below natural levels, preventing the D/H ratio from increasing to the threshold required for cell division. This in turn can serve as a key to reduce the relapse rate of cancer patients and/or to reduce cancer incidence in healthy populations. SAGE Publications 2022-01-19 /pmc/articles/PMC8777325/ /pubmed/35043700 http://dx.doi.org/10.1177/10732748211068963 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Article
Kovács, Beáta Zs.
Puskás, László G.
Nagy, Lajos I.
Papp, András
Gyöngyi, Zoltán
Fórizs, István
Czuppon, György
Somlyai, Ildikó
Somlyai, Gábor
Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients
title Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients
title_full Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients
title_fullStr Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients
title_full_unstemmed Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients
title_short Blocking the Increase of Intracellular Deuterium Concentration Prevents the Expression of Cancer-Related Genes, Tumor Development, and Tumor Recurrence in Cancer Patients
title_sort blocking the increase of intracellular deuterium concentration prevents the expression of cancer-related genes, tumor development, and tumor recurrence in cancer patients
topic Original Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777325/
https://www.ncbi.nlm.nih.gov/pubmed/35043700
http://dx.doi.org/10.1177/10732748211068963
work_keys_str_mv AT kovacsbeatazs blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients
AT puskaslaszlog blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients
AT nagylajosi blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients
AT pappandras blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients
AT gyongyizoltan blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients
AT forizsistvan blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients
AT czuppongyorgy blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients
AT somlyaiildiko blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients
AT somlyaigabor blockingtheincreaseofintracellulardeuteriumconcentrationpreventstheexpressionofcancerrelatedgenestumordevelopmentandtumorrecurrenceincancerpatients